Interventions for valvular disease and heart failure

Transcatheter aortic valve repair for aortic regurgitation with the Cusper device

EuroIntervention 2022;18:e179-e180. DOI: 10.4244/EIJ-D-22-00074

Yair Feld
Yair Feld1,2,3, MD, PhD; David Yakobi3, MD; Shalom Hazan3; Ariel Weigler3, MSc
1. Cardiology Department, Rambam Healthcare Campus, Haifa, Israel; 2. Technion – Israel Institute of Technology, School of Medicine, Haifa, Israel; 3. Cuspa LTD, Nazareth, Israel

Figure 1. The Cusper preclinical proof-of-concept study. A) The Cusper device. B) Delivery system capsule. C-F) Ex vivo model: en face view of a porcine aortic valve with aortic regurgitation induced by aortic root dilatation with and without the device at systolic and diastolic phases. G) Computed tomography planning: on the left – an en face view of the aortic valve post annular alignment and positioning of the axis in an overlap (of the RCC and LCC) view. The upper right figure shows the implantation angle and the delivery capsule superimposed on the image to provide exact implantation depth. H-I ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Post-release shift with Watchman FLX devices during left atrial appendage closure: the “popcorn effect”

Latest news